The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis

FASEB Journal

Volumn 17, Issue 2, 2003, Pages 214-222

  Brenner, Talma ^a   Hamra Amitay, Yasmine ^c   Evron, Tama ^c   Boneva, Neli ^a   Seidman, Shlomo ^c   Soreq, Hermona ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c NONE

Author keywords

Accetylcholine; MG; Neuromuscular function

Indexed keywords

ACETYLCHOLINESTERASE; ANTISENSE OLIGONUCLEOTIDE; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; GENE TARGETING; MUSCLE STRENGTH; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION DISORDER; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SURVIVAL;

ACETYLCHOLINESTERASE; ANIMALS; ELECTROMYOGRAPHY; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; RNA, MESSENGER;

ANIMALIA;

EID: 0037308205     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0609com     Document Type: Article

References (38)

1. Carlson, C. G. (1998) The dystrophinopathies: an alternative to the structural hypothesis. Neurobiol. Dis. 5, 3-15
2. Price, D. L., Koliatsos, V. E., and Clatterbuck, R. C. (1993) Cholinergic systems: human diseases, animal models, and prospects for therapy. Prog. Brain Res. 98, 51-60
3. Ohno, K., Engel, A. G., Brengman, J. M., Shen, X. M., Heidenreich, F., Vincent, A., Milone, M., Tan, E., Demirci, M., Walsh, P., Nakano, S., and Akiguchi, I. (2000) The spectrum of mutations causing end-plate acetylcholinesterase deficiency. Ann. Neurol. 47, 162-170
4. Vincent, A. (1999) Immunology of the neuromuscularjunction and presynaptic nerve terminal. Curr. Opin. Neurol. 12, 545-551
5. Behra, M., Cousin, X., Bertrand, C., Vonesch, J. L., Biellmann, D., Chatonnet, A., and Strahle, U. (2002) Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat. Neurosci. 5, 111-118
6. Soreq, H., and Seidman, S. (2001) Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2, 294-302
7. Kaufer, D., Friedman, A., Seidman, S., and Soreq, H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature (London) 393, 373-377
8. Shapira, M., Tur-Kaspa, I., Bosgraaf, L., Livni, N., Grant, A. D., Grisaru, D., Korner, M., Ebstein, R. P., and Soreq, H. (2000) A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9, 1273-1281
9. Meshorer, E., Erb, C., Gazit, R., Pavlovsky, L., Kaufer, D., Friedman, A., Glick, D., Ben-Arie, N., and Soreq, H. (2002) Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295, 508-512
10. Darboux, I., Barthalay, Y., Piovant, M., and Hipeau Jacquotte, R. (1996) The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J 15, 4835-4843
11. Sternfeld, M., Ming, G., Song, H., Sela, K., Timberg, R., Poo, M., and Soreq, H. (1998) Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18, 1240-1249
12. Lev-Lehmann, E., Evron, T., Broide, R. S., Meshorer, E., Ariel, I., Seidman, S., and Soreq, H. (2000) Synaptogenesis and myopathy under acetylcholinesterase overexpression. J. Mol. Neurosci. 14, 93-105
13. Perrier, A. L., Massoulie, J., and Krejci, E. (2002) PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33, 275-285
14. Seidman, S., Sternfeld, M., Ben Aziz Aloya, R., Timberg, R., Kaufer Nachum, D., and Soreq, H. (1995) Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3′-terminal exons. Mol. Cell. Biol. 15, 2993-3002
15. Drachman, D. B. (1994) Myasthenia gravis. N. Engl. J. Med. 330, 1797-1810
16. Wirguin, I., Brenner, T., Sicsic, C., and Argov, Z. (1994) Variable effect of calcium channel blockers on the decremental response in experimental autoimmune myasthenia gravis. Muscle Nerve 17, 523-527
17. Sternfeld, M., Shoham, S., Klein, O., Flores-Flores, C., Evron, T., Idelson, G. H., Kitsberg, D., Patrick, J. W., and Soreq, H. (2000) Excess "readthrough" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA 97, 8647-8652
18. Legay, C., Bon, S., Vernier, P., Coussen, F., and Massoulie, J. (1993) Cloning and expression of a rat acetylcholinesterase subunit: generation of multiple molecular forms and complementarity with a Torpedo collagenic subunit. J. Neurochem. 60, 337-346
19. Grifman, M., and Soreq, H. (1997) Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity. Antisense Nucleic Acid Drug Dev. 7, 351-359
20. Boneva, N., Brenner, T., and Argov, Z. (2000) Gabapentin may be hazardous in myasthenia gravis. Muscle Nerve 23, 1204-1208
21. Changeux, J. P., Galzi, J. L., Devillers-Thiery, A., and Bertrand, D. (1992) The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis. Q. Rev. Biophys. 25, 395-432
22. Mor, I., Grisaru, D., Titelbaum, L., Evron, T., Richler, C., Wahrman, J., Sternfeld, M., Yogev, L., Meiri, N., Seidman, S., and Soreq, H. (2001) Modified testicular expression of stress-associated "readthrough" acetylcholiensterase predicts male infertility. FASEB J 15, 2039-2041
23. Moran, D., Shapiro, Y., Meiri, U., Laor, A., Epstein, Y., and Horowitz, M. (1996) Exercise in the heat: Individual impacts of heat acclimation and exercise training on cardiovascular performance. J. Therm. Biol. 21, 171-181
24. Rossi, S. G., and Rotundo, R. L. (1993) Localization of "non-extractable" acetylcholinesterase to the vertebrate neuromuscular junction. J. Biol. Chem. 268, 19152-19159
25. Galyam, N., Grisaru, D., Grifman, M., Melamed-Book, N., Eckstein, F., Seidman, S., Eldor, A., and Soreq, H. (2001) Complex host cell responses to antisense suppression of ACHE gene expression. Antisense Nucl. Acid Drug Dev. 11, 51-57
26. Monia, B. P. (1997) First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinase. Ciba Found. Symp. 209, 107-119
27. He, F., Xu, H., Qin, F., Xu, L., Huang, J., and He, X. (1998) Intermediate myasthenia syndrome following acute organophosphates poisoning - an analysis of 21 cases. Hum. Exp. Toxicol. 17, 40-45
28. Millard, C. B., and Broomfield, C. A. (1995) Anticholinesterases: medical applications of neurochemical principles. J. Neurochem. 64, 1909-1918
29. Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., and Tracey, K. J. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (London) 405, 458-462
30. Tracey, K. J., Czura, C. J., and Ivanova, S. (2001) Mind over immunity. FASEB J. 15, 1575-1576
31. Huang, D., Shi, F. D., Giscombe, R., Zhou, Y., Ljunggren, H. G., and Lefvert, A. K. (2001) Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis. Eur. J. Immunol. 31, 225-232
32. Zhang, G. X., Xiao, B. G., Bai, X. F., van der Meide, P. H., Orn, A., and Link, H. (1999) Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J. Immunol. 162, 3775-3781
33. Ostlie, N. S., Karachunski, P. I., Wang, W., Monfardini, C., Kronenberg, M., and Conti-Fine, B. M. (2001) Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis. J. Immunol. 166, 4853-4862
34. Anglister, L., Haesaert, B., and McMahan, U. J. (1994) Globular and asymmetric acetylcholinesterase in the synaptic basal lamina of skeletal muscle. J. Cell Biol. 125, 183-196
35. Rotundo, R. L. (1990) Nucleus-specific translation and assembly of acetylcholinesterase in multinucleated muscle cells. J. Cell Biol. 110, 715-719
36. Dove, A. (2002) Antisense and sensibility. Nat. Biotechnol. 20, 121-124
37. Chan, R. Y., Adatia, F. A., Krupa, A. M., and Jasmin, B. J. (1998) Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J. Biol. Chem. 273, 9727-9733
38. Haley, R. W., Billecke, S., and La Du, B. N. (1999) Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol. Appl. Pharmacol. 157, 227-233